Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiko Watanabe

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
International Journal of Oncology|April 25, 2013
Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastomaTadashi Ashizawa, Haruo Miyata, Akira Iizuka, et al.
Cancer Science|June 2, 2023
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinomaYosuke Kagawa, Tokiko Nakai, Tetsuro Taki, et al.
European Journal of Clinical Pharmacology|October 29, 2015
Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemiaYoji Ishida, Kazunori Murai, Kohei Yamaguchi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinomaYutaro Tamiya, Tokiko Nakai, Ayako Suzuki, et al.
Annals of Hematology|August 6, 2021
Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation and Cellular Therapy|June 25, 2021
Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free SurvivalHideki Nakasone, Shinichi Kako, Takayoshi Tachibana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2023
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 CasesToru Odate, Kaishi Satomi, Takashi Kubo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation and Cellular Therapy|October 2, 2020
Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Leukemia|June 1, 2019
Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
International Journal of Oncology|April 25, 2013
Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastomaTadashi Ashizawa, Haruo Miyata, Akira Iizuka, et al.
Cancer Science|June 2, 2023
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinomaYosuke Kagawa, Tokiko Nakai, Tetsuro Taki, et al.
European Journal of Clinical Pharmacology|October 29, 2015
Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemiaYoji Ishida, Kazunori Murai, Kohei Yamaguchi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinomaYutaro Tamiya, Tokiko Nakai, Ayako Suzuki, et al.
Annals of Hematology|August 6, 2021
Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation and Cellular Therapy|June 25, 2021
Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free SurvivalHideki Nakasone, Shinichi Kako, Takayoshi Tachibana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2023
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 CasesToru Odate, Kaishi Satomi, Takashi Kubo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Transplantation and Cellular Therapy|October 2, 2020
Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Leukemia|June 1, 2019
Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
Pageof 22